Treatment with an intravaginal gel containing siliceous dioxide, selenite, and citric acid to promote regression of ASC-US-, LSIL, ASC-H, HSIL, p16/Ki61 status, and improve clearance of hr-HPV in cervical specimens
International Journal of Medical Device and Adjuvant Treatments · 2020-10 · 3
DOI: 10.32113/ijmdat_202010_270 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Device and Adjuvant Treatments, 2020-10. Verfasst von A. Müller und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
An intravaginal gel containing highly disperse siliceous dioxide (SiO2) and an anti-oxidative combination of citric acid and sodium selenite was tested for its ability to promote the regression of abnormal cytological findings and its influence on the hr-HPV status and tumor markers p16/Ki67 (CinTec-test). Patients and Methods: A historical control study was performed, including women (n=100) diagnosed with conspicuous cervical smears (ASC-US, LSIL, ASC-H, or HSIL). The gel was applied for 3x28 days. After three months, participants were analyzed for Pap status, hr-HPV strains, and expression of tumor markers p16/Ki67. Three months later, Pap testing and p16/Ki67 analysis were repeated. The results were compared to those of 106 women who met the same inclusion criteria but did not obtain any treatment.
Results
After six months, cytological Pap findings were improved in 80.9% of the participants in the treated group, and the clearing of hr-HPV was observed in 53% of cases. Only 5.3% were tested p16/Ki67 positive after six months in comparison to 75.0% at baseline. In the comparison group, 37.1% of the Pap smears and 18.6% of the CinTec results were improved, but no hr-HPV clearance was observed. The improvements were highly significant for the treatment.
Conclusions
The vaginal gel containing SiO2 and sodium selenite may support the healing of conspicuous cytological findings and clearance of hr-HPV.
Schlagwörter
Zitieren
APA
Müller, A., Sailer, M., & Regidor, P. (2020). Treatment with an intravaginal gel containing siliceous dioxide, selenite, and citric acid to promote regression of ASC-US-, LSIL, ASC-H, HSIL, p16/Ki61 status, and improve clearance of hr-HPV in cervical specimens. International Journal of Medical Device and Adjuvant Treatments, 3. https://doi.org/10.32113/ijmdat_202010_270
Vancouver
Müller A, Sailer M, Regidor P. Treatment with an intravaginal gel containing siliceous dioxide, selenite, and citric acid to promote regression of ASC-US-, LSIL, ASC-H, HSIL, p16/Ki61 status, and improve clearance of hr-HPV in cervical specimens. International Journal of Medical Device and Adjuvant Treatments. 2020;3. doi:10.32113/ijmdat_202010_270
BibTeX
@article{Mller2020,
author = {Müller, A. and Sailer, M. and Regidor, P.},
title = {Treatment with an intravaginal gel containing siliceous dioxide, selenite, and citric acid to promote regression of ASC-US-, LSIL, ASC-H, HSIL, p16/Ki61 status, and improve clearance of hr-HPV in cervical specimens},
journal = {International Journal of Medical Device and Adjuvant Treatments},
year = {2020},
volume = {3},
doi = {10.32113/ijmdat_202010_270}
}
EUVIMED